Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : EBS crawled time : 23:00 save search
Emergent BioSolutions Reports Third Quarter 2023 Financial Results
Published: 2023-11-08 (Crawled : 23:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: -4.07%
H: 6.13%
C: 1.42%
financial results
Emergent BioSolutions Reports FDA Advisory Committees’ Unanimous Vote in Favor of NARCAN® (naloxone HCI) Nasal Spray for Over-the-Counter Use
Published: 2023-02-15 (Crawled : 23:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: 8.71%
H: 1.85%
C: -8.88%
narcan fda spray
Emergent BioSolutions Awarded $379.6 Million Procurement Contract to Supply RSDL© (Reactive Skin Decontamination Lotion Kit) to U.S. Department of Defense
Published: 2023-01-05 (Crawled : 23:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: 3.72%
H: 8.04%
C: 5.85%
defense contract skin
Emergent BioSolutions Presents Data from Phase 2 Study Evaluating Safety and Immunogenicity of Chikungunya Vaccine Candidate in Prior Recipients of Other Alphavirus Vaccines
Published: 2022-11-01 (Crawled : 23:00) - biospace.com/
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: 1.87%
H: 1.46%
C: -1.55%
candidate vaccine study chikungunya
SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600
Published: 2021-11-22 (Crawled : 23:00) - prnewswire.com
SPGI | $412.56 -0.2% 0.0% 1.1M
|
Commercial Services
|
| O: -1.72%
H: 0.0%
C: 0.0%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: 5.89%
H: 3.86%
C: 0.9%
merge set
Opiant Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: -0.31%
H: 2.6%
C: 1.29%
OPNT | $20.65 -0.58% 0.48% 0
|
Health Technology
|
| O: 0.78%
H: 0.42%
C: 0.42%
financial results results
Emergent BioSolutions Inc. Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.
Published: 2021-05-07 (Crawled : 23:00) - prnewswire.com
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
| Email alert
Add to watchlist
merge
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.